These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


516 related items for PubMed ID: 17001880

  • 1. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 2. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R, Mansoor S.
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [Abstract] [Full Text] [Related]

  • 3. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 4. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.
    Sugiki T, Yamamoto M, Aruga A, Takasaki K, Nakano M.
    J Surg Oncol; 2004 Nov 01; 88(2):104-7. PubMed ID: 15499598
    [Abstract] [Full Text] [Related]

  • 5. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK, Prakash S, Geller SA, Alsabeh R.
    Hum Pathol; 2002 Dec 01; 33(12):1175-81. PubMed ID: 12514785
    [Abstract] [Full Text] [Related]

  • 6. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B, Boub R, Rahsaz M.
    Indian J Pathol Microbiol; 2007 Jul 01; 50(3):507-10. PubMed ID: 17883119
    [Abstract] [Full Text] [Related]

  • 7. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
    Kanitakis J, Chouvet B, Claudy A, Scoazec JY.
    Am J Clin Pathol; 2004 Jul 01; 122(1):85-9. PubMed ID: 15272534
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
    Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM.
    Am J Clin Pathol; 2004 Nov 01; 122(5):721-7. PubMed ID: 15491968
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB, Triratanachat S, Young RH, Oliva E.
    Int J Gynecol Pathol; 2004 Jan 01; 23(1):58-64. PubMed ID: 14668552
    [Abstract] [Full Text] [Related]

  • 10. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
    Maitra A, Murakata LA, Albores-Saavedra J.
    Am J Clin Pathol; 2001 May 01; 115(5):689-94. PubMed ID: 11345832
    [Abstract] [Full Text] [Related]

  • 11. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB, Segal A, Frost FA, Sterrett GF.
    Cancer; 2000 Oct 25; 90(5):273-8. PubMed ID: 11038423
    [Abstract] [Full Text] [Related]

  • 12. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W, Guo Q, Qu X, Inagaki Y, Seyama Y, Midorikawa Y, Gai R, Kokudo N, Sugawara Y, Nakata M, Makuuchi M.
    Oncol Rep; 2007 Apr 25; 17(4):737-41. PubMed ID: 17342308
    [Abstract] [Full Text] [Related]

  • 13. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec 25; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

  • 14. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.
    Am J Surg Pathol; 2008 Mar 25; 32(3):433-44. PubMed ID: 18300806
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb 25; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 16. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ.
    Am J Clin Pathol; 2003 Mar 25; 119(3):361-6. PubMed ID: 12645337
    [Abstract] [Full Text] [Related]

  • 17. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A.
    Cytopathology; 2008 Aug 25; 19(4):229-35. PubMed ID: 18070122
    [Abstract] [Full Text] [Related]

  • 18. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
    Fan Z, van de Rijn M, Montgomery K, Rouse RV.
    Mod Pathol; 2003 Feb 25; 16(2):137-44. PubMed ID: 12591966
    [Abstract] [Full Text] [Related]

  • 19. [Immunohistochemical spectrum in the detection and differentiation of intrahepatic neoplasms].
    Cong W, Tan L, Zhang S, Xian Z, Wu W, Pan J, Zhang X.
    Zhonghua Zhong Liu Za Zhi; 2002 Nov 25; 24(6):553-6. PubMed ID: 12667323
    [Abstract] [Full Text] [Related]

  • 20. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P.
    Magy Onkol; 2008 Dec 25; 52(4):379-83. PubMed ID: 19068466
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.